BIBF 1120 for Recurrent High-Grade Gliomas

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Boehringer Ingelheim
Wake Forest Baptist Health
University of Virginia
Massachusetts General Hospital
The Cleveland Clinic
Information provided by (Responsible Party):
Patrick Y. Wen, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01380782
First received: June 21, 2011
Last updated: March 20, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)